| Title |
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
|
|---|---|
| Published in |
Cochrane database of systematic reviews, November 2013
|
| DOI | 10.1002/14651858.cd002309.pub4 |
| Pubmed ID | |
| Authors |
Chong, Jimmy, Leung, Bonnie, Poole, Phillippa |
| Abstract |
Chronic obstructive pulmonary disease (COPD) is associated with cough, sputum production or dyspnoea and a reduction in lung function, quality of life and life expectancy. Apart from smoking cessation, there are no other treatments that slow lung function decline. Roflumilast and cilomilast are oral phosphodiesterase 4 (PDE4) inhibitors proposed to reduce the airway inflammation and bronchoconstriction seen in COPD. |
X Demographics
The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 20% |
| Indonesia | 1 | 10% |
| Spain | 1 | 10% |
| Unknown | 6 | 60% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 8 | 80% |
| Practitioners (doctors, other healthcare professionals) | 1 | 10% |
| Science communicators (journalists, bloggers, editors) | 1 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 165 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| United States | 1 | <1% |
| Italy | 1 | <1% |
| Unknown | 162 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 39 | 24% |
| Researcher | 27 | 16% |
| Student > Bachelor | 14 | 8% |
| Student > Postgraduate | 13 | 8% |
| Other | 11 | 7% |
| Other | 28 | 17% |
| Unknown | 33 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 58 | 35% |
| Psychology | 22 | 13% |
| Nursing and Health Professions | 12 | 7% |
| Social Sciences | 10 | 6% |
| Engineering | 4 | 2% |
| Other | 17 | 10% |
| Unknown | 42 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 July 2017.
All research outputs
#2,145,864
of 25,595,500 outputs
Outputs from Cochrane database of systematic reviews
#4,524
of 13,156 outputs
Outputs of similar age
#19,659
of 228,404 outputs
Outputs of similar age from Cochrane database of systematic reviews
#96
of 250 outputs
Altmetric has tracked 25,595,500 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,156 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 228,404 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 250 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.